SCHEMBL9953344

SCHEMBL9953344

O=CC(F)(F)c1cc(Br)ccc1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.35
KDM1A O60341 4/20 0.34
PTPN7 P35236 1/20 0.33
DUSP3 P51452 1/20 0.33
ERN1 O75460 1/20 0.33
USP28 Q96RU2 1/20 0.33
USP25 Q9UHP3 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA5A P35218 1/20 0.32
CA9 Q16790 1/20 0.32
KIF11 P52732 1/20 0.32
ALDH1A1 P00352 2/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
EPM2A O95278 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL690073 0.77 PTPN7 (0.47) DGAT1KDM1APTPN7DUSP3USP28
SCHEMBL29890371 0.77 PTPN7 (0.47) DGAT1KDM1APTPN7DUSP3USP28
SCHEMBL6923396 0.77 DGAT1 (0.36) DGAT1KDM1AERN1CA1CA2
SCHEMBL29465742 0.74 GRIN2B (0.39) DGAT1KDM1APTPN7DUSP3USP28
SCHEMBL28558021 0.74 KDM1A (0.37) DGAT1KDM1APTPN7DUSP3USP28
SCHEMBL4435565 0.74 GRIN2B (0.39) DGAT1KDM1APTPN7DUSP3USP28
SCHEMBL23003727 0.72 KDM1A (0.36) DGAT1KDM1APTPN7DUSP3USP28
SCHEMBL15145670 0.71 KCNN4 (0.42) ERN1KIF11
SCHEMBL3527105 0.71 PTGDR2 (0.42) DGAT1KDM1APTPN7DUSP3CA2
SCHEMBL16428016 0.71 PTGDR2 (0.38) DGAT1ALDH1A1NPC1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3194396-A1 DIAZINE-FUSED AMIDINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE Merck Sharp & Dohme Corp. (US) 2017-07-26 EP disclosed
WO-2016044120-A1 DIAZINE-FUSED AMIDINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2016-03-24 WO disclosed
EP-2718286-A1 HALOGEN-ALKYL-1,3 OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2014-04-16 EP disclosed
EP-2709992-A1 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. Hoffmann-La Roche AG (CH) 2014-03-26 EP disclosed
EP-2697208-A1 1,3 OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. Hoffmann-La Roche AG (CH) 2014-02-19 EP disclosed
EP-2681210-A1 1,4 THIAZEPINES/SULFONES AS BACE1 AND/OR BACE2 INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2014-01-08 EP disclosed
EP-2655376-A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) Janssen Pharmaceutica NV (BE) 2013-10-30 EP disclosed
WO-2012168164-A1 HALOGEN-ALKYL-1,3 OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-12-13 WO disclosed
WO-2012156284-A1 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-11-22 WO disclosed
WO-2012139993-A1 1,3 OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-10-18 WO disclosed
WO-2012119883-A1 1,4 THIAZEPINES/SULFONES AS BACE1 AND/OR BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-09-13 WO disclosed
WO-2012085038-A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) JANSSEN PHARMACEUTICA NV (BE) 2012-06-28 WO disclosed